Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy)

American Journal of Cardiology

Volumn 80, Issue 1, 1997, Pages 45-48

  Behrens, Steffen ^b   Ney, Gabriele ^b   Fisher, Susan Gross ^b   Fletcher, Ross D ^b   Franz, Michael R ^b   Singh, Steven N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; PLACEBO; VASODILATOR AGENT;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; ASYSTOLE; BRADYCARDIA; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUDDEN DEATH; SURVIVAL RATE;

AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; CIRCADIAN RHYTHM; DEATH, SUDDEN, CARDIAC; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 0009256161     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00281-6     Document Type: Article

References (23)

1. 1. Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-138.
2. 2. Willich SN, Levy D, Rocco MB, Tofler GH, Stone PH, Muller JE. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study Population. Am J Cardiol 1987;60:801-806.
3. 3. Moser DK, Stevenson WG, Woo MA, Stevenson LW. Timing of sudden death in patients with heart failure. J Am Coll Cardiol 1994;24:963-967.
4. 4. Lampert R, Rosenfeld L, Batsford W, Lee F, McPherson C. Circadian variation of sustained ventricular tachycardia in patients with coronary artery disease and implantable cardioverter-defibrillators. Circulation 1994;90:241-247.
5. 5. Mallavarapu C, Pancholy S, Schwartzman D, Callans DJ, Heo J, Gottlieb CD, Marchlinski FE. Circadian variation of ventricular arrhythmia recurrences after cardioverter-defibrillator implantation in patients with healed myocardial infarcts. Am J Cardiol 1995;75:1140-1144.
6. 6. Behrens S, Galecka M, Brüggemann T, Ehlers C, Willich SN, Ziss W, Dissmann R, Andresen D. Circadian variation of sustained ventricular tachyarrhythmias terminated by appropriate shocks in patients with an implantable defibrillator. Am Heart J 1995;130:79-84.
7. 7. Tofler GH, Gebara OCE, Mittleman MA, Taylor P, Siegel W, Venditti FJ, Rasmussen CA, Muller JE, for the CPI Investigators. Morning peak in ventricular tachyarrhythmias detected by time of implantable cardioverter/defibrillator therapy. Circulation 1995;92:1203-1208.
8. 8. Peters RW, Muller JE, Goldstein S, Byington R, Friedman LM, for the BHAT Study Group. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT study). Am J Cardiol 1989;63:1518-1520.
9. 9. Behrens S, Ehlers C, Brüggemann T, Ziss W, Dissmann R, Galecka M, Willich SN, Andresen D. Modification of the circadian pattern of ventricular tachyarrhythmias by beta-blocker therapy. Clin Cardiol 1997;20:253-257.
10. 10. Peters RW, Mitchell LB, Brooks MM, Echt DS, Barker AH, Capone R, Liebson PR, Greene HL, for the CAST investigators. Circadian pattern of arrhythmic death in patients receiving encainide, flecainide or moricizine in the Cardiac Arrhythmia Suppression Trial (CAST). J AM Coll Cardiol 1994;23:283-289.
11. 11. Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82.
12. 12. Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL. Congestive heart failure: survival trial of antiarrhythmic therapy (CHF STAT). The CHF STAT Investigators. Controlled Clin Trials 1992;13: 339-350.
13. 13. Singh S, Fletcher RD, Fisher S, Deedwania P, Lewis D, Massie B, Singh B, Colling CL. Veterans Affairs Congestive Heart Failure Antiarrhythmic Trial. Am J Cardiol 1993;72:99F-102F.
14. 14. Willich SN, Maclure M, Mittleman M, Arntz HJ, Muller JE. Sudden cardiac death. Support for a role of triggering in causation. Circulation 1993;87:1442-1450.
15. 15. Amtz HR, Willich SN, Oeff M, Brüggemann T, Stern H, Heinzmann A, Matenaer B, Schröder R. Circadian variation of sudden cardiac death reflects age-related variability in ventricular fibrillation. Circulation 1993;88:2284-2289.
16. 16. Hohnloser SH, Klingenheben T. Insights into the pathogenesis of sudden cardiac death from analysis of circadian fluctuations of potential triggering factors. PACE 1994;17:428-433.
17. 17. Braunwald E. Morning resistance to thrombolytic therapy. Circulation 1995;91:1604-1606.
18. 18. Rocco MB, Barry J, Campbell S, Nabel E, Cook F, Goldman L, Selwyn AP. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 1987;75:395-400.
19. 19. Willich SN, Linderer T, Wegscheider K, Leizorovicz A, Alamercery I, Schröder R, and the ISAM Study Group. Increased morning incidence of myocardial infarction in the ISAM study: absence with prior beta-adrenergic blockade. Circulation 1989;80:853-858.
20. 20. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, Sobel BE, Willerson JT, Braunwald E, and the MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313: 1315-1322.
21. 21. Tsementzis SA, Gill JS, Hitchcock ER, Gill SK, Beevers DG. Diurnal variation of and activity during the onset of stroke. Neurosurgery 1985;17:901-904.
22. 22. Colantonio D, Casale R, Abruzzo BP, Lorenzetti G, Pasqualetti P. Circadian distribution in fatal pulmonary thromboembolism. Am J Cardiol 1989;64:403-404.
23. 23. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743.